NUTX
$94.01
Nutex Health Inc.
Recent News
Nutex Health Inc (NUTX) Q4 2025 Earnings Call Highlights: Robust Annual Growth Amid Quarterly ...
Nutex Health Inc (NUTX) reports an impressive 82% annual revenue increase, despite facing a significant Q4 revenue reduction due to arbitration claims.
Nutex Health (NUTX) Is Down 23.2% After Earnings Miss, IDR Issues, And New Buyback - What's Changed
Nutex Health reported full-year 2025 results on March 5, 2026, with revenue of US$875.26 million and net income of US$70.79 million, while Q4 earnings per share of US$1.61 came in well below expectations and revenue fell year-on-year. At the same time, the company disclosed IDR-related reimbursement issues that triggered legal scrutiny and paired them with completing one US$25 million buyback and authorizing another to offset dilution and signal confidence. We’ll now examine how the earnings...
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks declined late Friday afternoon, with the NYSE Health Care Index and the State Str
Nutex Health Q4 Earnings Call Highlights
Nutex Health (NASDAQ:NUTX) management highlighted sharp full-year revenue and earnings growth in 2025, improved cash generation, and continued progress navigating reimbursement under the Independent Dispute Resolution (IDR) process, while acknowledging a one-time fourth-quarter revenue reduction tie
Stocks Retreat Amid Inflation Fears and Weak US Jobs
The S&P 500 Index ($SPX ) (SPY ) today is down -0.95%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.76%. March E-mini S&P futures (ESH26 ) are down -0.95%, and March E-mini Nasdaq futures...